McKesson Announces Bansi Nagji to Step Down as Executive Vice President, Chief Strategy and Business Development Officer
IRVING, Texas, March 23, 2020 —McKesson Corporation (NYSE:MCK) today announced that Bansi Nagji, executive vice president and chief strategy and business development officer, will step down from his role effective March 31, 2020. Mr. Nagji has agreed to continue employment with the company for severa... (Source: McKesson News)
Source: McKesson News - March 23, 2020 Category: Information Technology Source Type: news
DOPTELET (avatrombopag) Now Available at Biologics by McKesson
CARY, N.C., March 19, 2020 —Biologics by McKesson, an independent specialty pharmacy for oncology and complex care, was selected by AkaRx, Inc., a subsidiary of Dova Pharmaceuticals, Inc., as a specialty pharmacy provider in a limited distribution network for DOPTELET® (avatrombopag). Dova, which rec... (Source: McKesson News)
Source: McKesson News - March 19, 2020 Category: Information Technology Source Type: news
McKesson Updates Fiscal 2020 Guidance Following Completion of Change Healthcare Split-Off
IRVING, Texas, March 17, 2020 —McKesson Corporation (NYSE:MCK) today announced it is updating its adjusted earnings outlook for the fiscal year ending March 31, 2020 to reflect the completion of the company’s exit of its investment in Change Healthcare, as announced on March 10, 2020. (Source: McKesson News)
Source: McKesson News - March 17, 2020 Category: Information Technology Source Type: news
McKesson Announces Final Results of Exchange Offer
IRVING, TEXAS — March 12, 2020 — McKesson Corporation (NYSE:MCK) today announced the final results of its offer to its stockholders to exchange their issued and outstanding shares of McKesson common stock for shares of PF2 SpinCo, Inc. (“SpinCo”) common stock owned by McKesson as part of its split-o... (Source: McKesson News)
Source: McKesson News - March 12, 2020 Category: Information Technology Source Type: news
McKesson Announces Preliminary Results of Exchange Offer
IRVING, TEXAS — March 10, 2020 — McKesson Corporation (NYSE:MCK) today announced that its previously announced offer to stockholders to exchange their shares of McKesson common stock on a per-share-basis for 11.4086 shares of PF2 SpinCo, Inc. (“SpinCo”) common stock expired at 11:59 p.m., New York C... (Source: McKesson News)
Source: McKesson News - March 10, 2020 Category: Information Technology Source Type: news
McKesson Completes Split-off of Its Interest in Change Healthcare
IRVING, TEXAS — March 10, 2020 — McKesson Corporation (NYSE:MCK) today announced the completion of the split-off of PF2 SpinCo, Inc. (“SpinCo”), which held McKesson’s interest in Change Healthcare LLC (“Change Healthcare”) and which was merged with and into Change Healthcare Inc. (NASDAQ:CHNG) (“ Cha... (Source: McKesson News)
Source: McKesson News - March 10, 2020 Category: Information Technology Source Type: news
McKesson Sets Final Exchange Ratio of 11.4086 for Exchange Offer
IRVING, TEXAS — March 5, 2020 — McKesson Corporation (NYSE:MCK) today announced the final exchange ratio of 11.4086-for-one in connection with its previously announced offer to its stockholders to exchange their shares of McKesson common stock for shares of PF2 SpinCo, Inc. (“SpinCo”) common stock. ... (Source: McKesson News)
Source: McKesson News - March 5, 2020 Category: Information Technology Source Type: news
Health Mart Independent Pharmacies Donate Their Dispensing Services to HHS to Support “Ending the HIV Epidemic” Initiative
The U.S. Department of Health and Human Services (HHS) and Health Mart today announced that more than 3,300 Health Mart independent pharmacies agreed to donate their dispensing services to support Ready, Set, PrEP, the HHS program that provides free PrEP medication to uninsured individuals. As part ... (Source: McKesson News)
Source: McKesson News - March 3, 2020 Category: Information Technology Source Type: news
McKesson Launches Exchange Offer to Split-Off Its Interest in Change Healthcare
IRVING, TEXAS —February 10, 2020—McKesson Corporation (NYSE:MCK) today announced the commencement of an exchange offer for the split-off of its wholly-owned subsidiary, PF2 SpinCo, Inc. (“SpinCo”), which will hold all of McKesson’s interest in Change Healthcare LLC (“Change Healthcare”), as part of M... (Source: McKesson News)
Source: McKesson News - February 10, 2020 Category: Information Technology Source Type: news
McKesson Reports Fiscal 2020 Third-Quarter Results
Third Quarter Highlights, Year-over-Year: (Source: McKesson News)
Source: McKesson News - February 4, 2020 Category: Information Technology Source Type: news
McKesson Declares Quarterly Dividend
IRVING, Texas, January 29, 2020 —The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 41 cents per share of common stock. The dividend will be payable on April 1, 2020, to stockholders of record on March 2, 2020. (Source: McKesson News)
Source: McKesson News - January 29, 2020 Category: Information Technology Source Type: news
McKesson Recognized as one of the “Best Places to Work for LGBTQ Equality” for Seventh Year in a Row
IRVING, Texas, Jan. 27, 2020 — For the seventh consecutive year, McKesson Corporation is honored as one of the “Best Places to Work for LGBTQ Equality” by the Human Rights Campaign (HRC) Foundation. McKesson achieved 100 percent on the HRC’s 2020 Corporate Equality Index (CEI), a nationally recognize... (Source: McKesson News)
Source: McKesson News - January 27, 2020 Category: Information Technology Source Type: news
AYVAKIT ™ (avapritinib), FDA Approved for Treatment of PDGFRA Exon 18 Mutant GIST, Available at Biologics by McKesson
CARY, N.C., Jan. 17, 2020 —Biologics by McKesson, an independent specialty pharmacy for oncology and other rare and complex therapeutic areas, has been selected by Blueprint Medicines Corporation as a specialty pharmacy provider for AYVAKITTM (avapritinib) for the treatment of adults with unresectabl... (Source: McKesson News)
Source: McKesson News - January 17, 2020 Category: Information Technology Source Type: news
McKesson Designated as 2020 Qualified Clinical Data Registry by CMS
IRVING, Texas, Jan. 16, 2020 —For the fourth consecutive year, McKesson has received approval from the Centers for Medicare and Medicaid Services (CMS) to participate in the Merit-based Incentive Payment System (MIPS) program as a Qualified Clinical Data Registry (QCDR). With this designation for the... (Source: McKesson News)
Source: McKesson News - January 16, 2020 Category: Information Technology Source Type: news
McKesson to Present at the 38th Annual J.P. Morgan Healthcare Conference: Will Provide Company Overview and Review Updated Financial Outlook
IRVING, Texas, January 13, 2020 —McKesson Corporation (NYSE:MCK) will present at the 38th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco tomorrow, January 14, 2020 at 9:00 AM PT (12:00 PM ET). Brian Tyler, chief executive officer of McKesson, will provide a ... (Source: McKesson News)
Source: McKesson News - January 13, 2020 Category: Information Technology Source Type: news
